Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Colombia: 3,177 Pregnant Women with Zika; No Microcephaly

By Drug Discovery Trends Editor | February 9, 2016

An Aedes aegipty female mosquito floats on stagnant water inside a tire at a used tire store in Villavicencio, Colombia, Thursday, Feb. 4, 2016. The Aedes aegipty is the vector that transmits the Zika virus, and also dengue, yellow fever and chikungunya. The females lay their eggs on damp surfaces where they breed. (AP Photo/Fernando Vergara)Colombia’s President Juan Manuel Santos said Saturday that there’s no evidence Zika has caused any cases of the birth defect known as microcephaly in his country, though it has diagnosed 3,177 pregnant women with the virus.

Santos also announced that a U.S. medical-scientific team will arrive in Colombia to help investigate the mosquito-borne virus.

Brazilian officials say they suspect Zika is behind a seemingly unusual number of microcephaly cases, in which children are born with unusually small heads. The link is not confirmed, but it has helped prompt the World Health Organization to declare an emergency over the virus.

Santos said Zika apparently has affected more than 25,600 Colombians overall.

Colombian officials said Friday that three people had died of the paralyzing Guillain-Barre syndrome they attributed to cases of Zika.

To date, the mosquito-borne virus has spread to more than 20 countries in the Americas.

With global concern over the Zika virus growing, health officials are warning pregnant women to be careful about who they kiss and calling on men to use condoms with pregnant partners if they have visited countries where the virus is present.

The flurry of recommendations began in Brazil, where a top health official said that scientists have found live virus in saliva and urine samples, and the possibility it could be spread by the two body fluids requires further study.

Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Roche in Drug Discovery & Development Pharma 50
Roche’s bispecific antibody Lunsumio wins priority review from FDA for non-Hodgkin lymphoma
Tiffany Hurd
CB Therapeutics biz dev lead sees upside for psychedelics in mental health and beyond
Pharmacovigilance
A new era of pharmacovigilance: Worldwide master key for drug safety monitoring
Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50